Table 5.
coumarin 7-hydroxylation (nmol/min/nmol P450) |
||
---|---|---|
without preincubation | with preincubation | |
P450 2A6 | ||
control | 3.26 (100) | 3.06 (100) |
+ BSC (4.3 µM) | 1.70 (52) | 1.52 (50) |
+ m-XSC (0.68 µM) | 1.56 (48) | 1.46 (48) |
P450 2A13 | ||
control | 1.04 (100) | 0.98 (100) |
+ BSC (1.2 µM) | 0.49 (47) | 0.48 (49) |
+ m-XSC (0.22 µM) | 0.59 (56) | 0.53 (54) |
BSC and m-XSC were preincubated with recombinant P450 2A6 and 2A13 systems fortified with NADPH for 0 or 15 min and the catalytic activities were determined after adding 1.0 µM coumarin. Values in parentheses indicate % of control. Results are presented as means of triplicate determinations. There were no significant differences in the inhibition of coumarin 7-hydroxylation activities by BSC and m-XSC with and without preincubation.